Cell penetrating peptides: Highlighting points in cancer therapy.
Saved in:
| Title: | Cell penetrating peptides: Highlighting points in cancer therapy. |
|---|---|
| Authors: | Asrorov, Akmal M., Wang, Huiyuan, Zhang, Meng, Wang, Yonghui, He, Yang, Sharipov, Mirkomil, Yili, Abulimiti, Huang, Yongzhuo |
| Source: | Drug Development Research; Sep2023, Vol. 84 Issue 6, p1037-1071, 35p |
| Subject Terms: | CELL-penetrating peptides, PEPTIDES, CANCER treatment, AMINO acid sequence, DRUG delivery systems |
| Abstract: | Cell‐penetrating peptides (CPPs), first identified in HIV a few decades ago, deserved great attention in the last two decades; especially to support the penetration of anticancer drug means. In the drug delivery discipline, they have been involved in various approaches from mixing with hydrophobic drugs to the use of genetically conjugated proteins. The early classification as cationic and amphipathic CPPs has been extended to a few more classes such as hydrophobic and cyclic CPPs so far. Developing potential sequences utilized almost all methods of modern science: choosing high‐efficiency peptides from natural protein sequences, sequence‐based comparison, amino acid substitution, obtaining chemical and/or genetic conjugations, in silico approaches, in vitro analysis, animal experiments, etc. The bottleneck effect in this discipline reveals the complications that modern science faces in drug delivery research. Most CPP‐based drug delivery systems (DDSs) efficiently inhibited tumor volume and weight in mice, but only in rare cases reduced their levels and continued further processes. The integration of chemical synthesis into the development of CPPs made a significant contribution and even reached the clinical stage as a diagnostic tool. But constrained efforts still face serious problems in overcoming biobarriers to reach further achievements. In this work, we reviewed the roles of CPPs in anticancer drug delivery, focusing on their amino acid composition and sequences. As the most suitable point, we relied on significant changes in tumor volume in mice resulting from CPPs. We provide a review of individual CPPs and/or their derivatives in a separate subsection. [ABSTRACT FROM AUTHOR] |
| Copyright of Drug Development Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Complementary Index |
Full Text Finder 
Nájsť tento článok vo Web of Science Be the first to leave a comment!